Liraglutide reduces lipogenetic signals in visceral adipose of db/db mice with AMPK activation and Akt suppression
Yimin Shao, Geheng Yuan, Junqing Zhang, Xiaohui Guo Department of Endocrinology, Peking University First Hospital, Beijing, People’s Republic of China Abstract: Liraglutide, a glucagon-like peptide-1 analog, has been proved to reduce body weight and visceral adipose tissue (VAT) in human s...
Saved in:
Main Authors: | Shao Y (Author), Yuan G (Author), Zhang J (Author), Guo X (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dioscin Reduces Vascular Damage in the Retina of db/db Mice by Inhibiting the VEGFA Signaling Pathway
by: Jun Wang, et al.
Published: (2022) -
Antidiabetic Effect of Tibetan Medicine Tang-Kang-Fu-San in db/db Mice via Activation of PI3K/Akt and AMPK Pathways
by: Bailu Duan, et al.
Published: (2017) -
Dapagliflozin protects against nonalcoholic steatohepatitis in db/db mice
by: Panshuang Qiao, et al.
Published: (2022) -
Beneficial Effects of Echinacoside on Diabetic Cardiomyopathy in Diabetic Db/Db Mice
by: Zhang X, et al.
Published: (2020) -
Exenatide regulates Th17/Treg balance via PI3K/Akt/FoxO1 pathway in db/db mice
by: Qinqin Xu, et al.
Published: (2022)